|
Name |
3-Methoxy-2-methyl-4H-pyran-4-one
|
Molecular Formula | C7H8O3 | |
IUPAC Name* |
3-methoxy-2-methylpyran-4-one
|
|
SMILES |
CC1=C(C(=O)C=CO1)OC
|
|
InChI |
InChI=1S/C7H8O3/c1-5-7(9-2)6(8)3-4-10-5/h3-4H,1-2H3
|
|
InChIKey |
NGGPLHHTRNJSDT-UHFFFAOYSA-N
|
|
Synonyms |
3-Methoxy-2-methyl-4H-pyran-4-one; 4780-14-7; 3-methoxy-2-methylpyran-4-one; 4H-Pyran-4-one, 3-methoxy-2-methyl-; 2-Methyl-3-methoxy-4H-pyran-4-one; 3-methoxy-2-methyl-4-pyrone; 3-Methoxy-2-Methyl-pyran-4-one; SCHEMBL7100551; 3-Methoxy-2-methyl-4-pyranone; DTXSID10343137; ALBB-027294; MFCD14553191; ZINC32179613; AKOS015995164; 3-Methoxy-2-methyl-4H-pyran-4-one #; LS-09349; CS-0153636; D82596; EN300-129191
|
|
CAS | 4780-14-7 | |
PubChem CID | 587693 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 140.14 | ALogp: | 0.7 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 35.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.591 |
Caco-2 Permeability: | -4.463 | MDCK Permeability: | 0.00002760 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.724 | Plasma Protein Binding (PPB): | 76.43% |
Volume Distribution (VD): | 1.309 | Fu: | 35.01% |
CYP1A2-inhibitor: | 0.672 | CYP1A2-substrate: | 0.881 |
CYP2C19-inhibitor: | 0.284 | CYP2C19-substrate: | 0.865 |
CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.653 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.742 |
CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.453 |
Clearance (CL): | 7.028 | Half-life (T1/2): | 0.792 |
hERG Blockers: | 0.123 | Human Hepatotoxicity (H-HT): | 0.152 |
Drug-inuced Liver Injury (DILI): | 0.154 | AMES Toxicity: | 0.202 |
Rat Oral Acute Toxicity: | 0.699 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.443 | Carcinogencity: | 0.845 |
Eye Corrosion: | 0.223 | Eye Irritation: | 0.861 |
Respiratory Toxicity: | 0.757 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000292 | 0.545 | D0G4KG | 0.356 | ||||
ENC003235 | 0.333 | D08SKH | 0.327 | ||||
ENC000078 | 0.327 | D0N0OU | 0.293 | ||||
ENC006095 | 0.326 | D0E9CD | 0.239 | ||||
ENC006031 | 0.321 | D0X0RI | 0.216 | ||||
ENC005716 | 0.308 | D06GCK | 0.215 | ||||
ENC005717 | 0.308 | D0L1WV | 0.206 | ||||
ENC004675 | 0.296 | D0S5CH | 0.200 | ||||
ENC001623 | 0.291 | D02DPU | 0.200 | ||||
ENC000172 | 0.286 | D07PAO | 0.197 |